The case for transmissible antivirals to control population-wide infectious disease

Fine, 1993, Herd immunity: history, theory, practice, Epidemiol. Rev., 15, 265, 10.1093/oxfordjournals.epirev.a036121 Jiles, 2000, Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school, MMWR Morb. Mortal. Wkly. Rep., 49, 27 Luman, 2001, National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999, Am. J. Prev. Med., 20, 88, 10.1016/S0749-3797(01)00274-4 Hethcote, 1984 Anderson, 1991 Woolhouse, 1997, Heterogeneities in the transmission of infectious agents: implications for the design of control programs, Proc. Natl. Acad. Sci. U.S.A., 94, 338, 10.1073/pnas.94.1.338 Lloyd-Smith, 2005, Superspreading and the effect of individual variation on disease emergence, Nature, 438, 355, 10.1038/nature04153 van de Laar, 2009, Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men, Gastroenterology, 136, 1609, 10.1053/j.gastro.2009.02.006 Grassly, 2005, Host immunity and synchronized epidemics of syphilis across the United States, Nature, 433, 417, 10.1038/nature03072 Woodhouse, 1994, Mapping a social network of heterosexuals at high risk for HIV infection, AIDS, 8, 1331, 10.1097/00002030-199409000-00018 May, 1987, Transmission dynamics of HIV infection, Nature, 326, 137, 10.1038/326137a0 Graw, 2012, Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia, Epidemics, 4, 104, 10.1016/j.epidem.2012.04.002 Cowan, 2005, The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or money, J. Acquir. Immune Defic. Syndr., 38, 202, 10.1097/00126334-200502010-00012 Sovran, 2013, Understanding culture and HIV/AIDS in sub-Saharan Africa, SAHARA J., 10, 32 Swidler, 2007, Ties of dependence: AIDS and transactional sex in rural Malawi, Stud. Fam. Plann., 38, 147, 10.1111/j.1728-4465.2007.00127.x Kahn, 1996, The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?, Am. J. Public Health, 86, 1709, 10.2105/AJPH.86.12.1709 Granich, 2009, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model, Lancet, 373, 48, 10.1016/S0140-6736(08)61697-9 Montaner, 2006, The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic, Lancet, 368, 531, 10.1016/S0140-6736(06)69162-9 Baggaley, 2006, Modelling the impact of antiretroviral use in resource-poor settings, PLoS Med., 3, e124, 10.1371/journal.pmed.0030124 Garnett, 2009, Treating our way out of the HIV pandemic: could we, would we, should we?, Lancet, 373, 9, 10.1016/S0140-6736(08)61698-0 Metzger, 2011, Autonomous targeting of infectious superspreaders using engineered transmissible therapies, PLoS Comput. Biol., 7, e1002015, 10.1371/journal.pcbi.1002015 Baggaley, 2005, The epidemiological impact of antiretroviral use predicted by mathematical models: a review, Emerg. Themes Epidemiol., 2, 9, 10.1186/1742-7622-2-9 Rouzine, 2013, Design requirements for interfering particles to maintain coadaptive stability with HIV-1, J. Virol., 87, 2081, 10.1128/JVI.02741-12 Rouzine, 2013, Reply to ‘Coadaptive Stability of Interfering Particles with HIV-1 When There Is an Evolutionary Conflict’, J. Virol., 87, 9960, 10.1128/JVI.00932-13 Weinberger, 2003, Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection, J. Virol., 77, 10028, 10.1128/JVI.77.18.10028-10036.2003 Huang, 1970, Defective viral particles and viral disease processes, Nature, 226, 325, 10.1038/226325a0 Holland, 1990, Generation and replication of defective viral genomes, 77 Aaskov, 2006, Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes, Science, 311, 236, 10.1126/science.1115030 Levine, 2006, Gene transfer in humans using a conditionally replicating lentiviral vector, Proc. Natl. Acad. Sci. U.S.A., 103, 17372, 10.1073/pnas.0608138103 Tebas, 2013, Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV, Blood, 121, 1524, 10.1182/blood-2012-07-447250 Morris, 2005, Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1, Hum. Gene Ther., 16, 1463, 10.1089/hum.2005.16.1463 Dukers, 2001, Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection, AIDS, 15, 369, 10.1097/00002030-200102160-00010 Blower, 2000, A tale of two futures: HIV and antiretroviral therapy in San Francisco, Science, 287, 650, 10.1126/science.287.5453.650 Fine, 1999, Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative, Am. J. Epidemiol., 150, 1001, 10.1093/oxfordjournals.aje.a009924 Ke, 2013, Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses, PLoS Pathog., 9, e1003193, 10.1371/journal.ppat.1003193 Li, 2011, Defective interfering viral particles in acute dengue infections, PLoS ONE, 6, e19447, 10.1371/journal.pone.0019447 Porco, 2005, The effect of treatment on pathogen virulence, J. Theor. Biol., 233, 91, 10.1016/j.jtbi.2004.09.009 Nowak, 1994, Superinfection and the evolution of parasite virulence, Proc. Biol. Sci., 255, 81, 10.1098/rspb.1994.0012 Fraser, 2014, Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective, Science, 343, 1243727, 10.1126/science.1243727 Schambach, 2013, Biosafety features of lentiviral vectors, Hum. Gene Ther., 24, 132, 10.1089/hum.2012.229 Modlich, 2009, Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors, Mol. Ther., 17, 1919, 10.1038/mt.2009.179 McGarrity, 2013, Patient monitoring and follow-up in lentiviral clinical trials, J. Gene Med., 15, 78, 10.1002/jgm.2691 Scholler, 2012, Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells, Sci. Transl. Med., 4, 132ra153, 10.1126/scitranslmed.3003761 Pike-Overzet, 2007, New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy, Mol. Ther., 15, 1910, 10.1038/sj.mt.6300297 Bordignon, 1995, Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients, Science, 270, 470, 10.1126/science.270.5235.470 Dunleavy, 2012, How I treat HIV-associated lymphoma, Blood, 119, 3245, 10.1182/blood-2011-08-373738 Davis, 2004, In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication, Mol. Ther., 9, 160, 10.1016/j.ymthe.2003.11.003 Mukherjee, 2010, HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model, Mol. Ther., 18, 803, 10.1038/mt.2009.316 Chong, 1998, A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences, J. Virol., 72, 2663, 10.1128/JVI.72.4.2663-2670.1998 Aiuti, 2013, Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott–Aldrich syndrome, Science, 341, 1233151, 10.1126/science.1233151 Biffi, 2013, Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy, Science, 341, 1233158, 10.1126/science.1233158 Baeten, 2012, Antiretroviral prophylaxis for HIV prevention in heterosexual men and women, N. Engl. J. Med., 367, 399, 10.1056/NEJMoa1108524